India has introduced a set of measures aimed at strengthening medicine safety, monitoring adverse drug reactions and improving the reporting of medical device-related incidents.
Union Minister of State for Health and Family Welfare Anupriya Patel launched the seventh edition of the National Formulary of India along with new guidance for hospitals on safety monitoring and reporting of adverse events linked to medical devices.
The National Formulary of India provides information intended to support the rational and safe use of medicines in the country. The latest edition is expected to serve as a reference for healthcare professionals and institutions.
The government also launched guidance for hospitals on the monitoring and reporting of medical device-related adverse events. The initiative is aimed at strengthening systems through which hospitals can identify and report problems associated with medical devices.
Another development announced on Friday was the Pharmacovigilance Programme of India 2.0 mobile application for iOS users. The application is part of ongoing efforts to make adverse drug reaction reporting more accessible through digital platforms.
Pharmacovigilance involves monitoring medicines after they enter wider use and identifying possible adverse effects or safety concerns. Timely reporting can help healthcare authorities assess emerging risks and take appropriate regulatory measures.
The latest initiatives are part of India’s continuing efforts to strengthen patient safety and improve monitoring across the healthcare system.
With medicines and medical devices playing an expanding role in diagnosis and treatment, systematic reporting of adverse events remains an important part of healthcare regulation. The new guidance and digital tools are expected to support hospitals, healthcare professionals and regulators in strengthening this process.
Comment here